Spots Global Cancer Trial Database for Induced-T Cell Like NK Cells for B Cell Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Induced-T Cell Like NK Cells for B Cell Malignancies
Official Title: Induced-T Cell Like NK Cellular Immunotherapy for Refractory B Cell Malignancies
Study ID: NCT04747093
Interventions
Study Description
Brief Summary: Relapsed and refractory B cell malignancies show unfavorable prognosis, especially for adult patients. Now, there is no standard management for these patients. Induced-T cell-like NK cells with chimeric antigen receptor (CAR-ITNK cells) is a promising treatment option for treating B cell derived malignancy. The purpose of this study is to evaluate the efficacy and safety of CAR-ITNK cells infusions in patients with relapsed and refractory B cell malignancies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Contact Details
Name: Qi-fa Liu
Affiliation: Nanfang Hospital, Southern Medical University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
